Impact Ethics

Disclaimer
Submit A Post
About
The Body Economy

Making a Difference in Bioethics

Tag Archives: Deborah Gleeson

Monopolies on New Medicines & Trade with the U.S.

November 14, 2018 · by impact ethics · in Pharmaceuticals, Public Health, Science and Technology

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Learn about The Body Economy

Read Impact Ethics posts on The Body Economy

Watch: The Body Economy: Human Eggs in the Marketplace

Watch: The Body Economy: Surrogacy in the Marketplace

Watch: The Body Economy: Blood products in the Marketplace

Watch: The Body Economy: Breast milk in the Marketplace

Watch: The Body Economy: Organs in the Marketplace

Follow us on Twitter

Subscribe by email

Topics

Subscribe by RSS Feed

Bioethics Forum

Immigrant Health in the Public Charge Era: 15 Essential Articles

Biopolitical Times

The Geneva Statement

Fear & Loathing in Bioethics

Who should survive?

Healthy Debate

Can wastewater monitoring help inform future drug prevention strategies?

Practical Ethics

Pandemic Ethics: Should Frontline Doctors and Nurses Get Preferential Treatment?

Archives

Blog at WordPress.com.